Syngenta Group Ventures — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

Metabolon, Inc.metabolon.com in 𝕏Aug 2016SEC filingmedium confidence

Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.

AI & Machine LearningBiotechHealthtechDurham, US

John A. Ryals(Executive Officer, Director)inGerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)inJohn Ryals, Ph.D(Founder)Rohan (Ro) F. Hastie, Ph.D.(President & Chief Executive Officer)

BoardJohn Oxaal(Director)

Board seatDavid Pierson· per SEC Form D · $48M raise · filed Sep 2020

Co-investorsCamden Partners Essex Woodlands Healthcare Partners Havencrest Capital Management Revelation Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.